These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
5. Angiotensin converting enzyme inhibitors in the treatment of hypertension. Materson BJ Compr Ther; 1983 Oct; 9(10):14-20. PubMed ID: 6196149 [TBL] [Abstract][Full Text] [Related]
6. Development of specific inhibitors of angiotensin I converting enzyme (kininase II). Cushman DW; Cheung HS; Sabo EF; Rubin B; Ondetti MA Fed Proc; 1979 Dec; 38(13):2778-82. PubMed ID: 228989 [No Abstract] [Full Text] [Related]
7. [Calcium channel blockers and angiotensin converting enzyme inhibitors in the treatment of high blood pressure]. Koster M Ned Tijdschr Geneeskd; 1986 Aug; 130(34):1509-13. PubMed ID: 3020442 [No Abstract] [Full Text] [Related]
8. [Some advances in angiotensin converting enzyme inhibitors]. Jia L Sheng Li Ke Xue Jin Zhan; 1985 Jul; 16(3):229-34. PubMed ID: 3003897 [No Abstract] [Full Text] [Related]
9. Angiotensin-converting enzyme inhibitors. Dipalma JR Am Fam Physician; 1980 Nov; 22(5):164-5. PubMed ID: 6158857 [No Abstract] [Full Text] [Related]
10. [Drug information. New principle in the treatment of elevated blood pressure]. Dahlerup J Sygeplejersken; 1985 Jul; 85(27):16-7. PubMed ID: 3000014 [No Abstract] [Full Text] [Related]
11. [From teprotide to captopril. Rational design of ACE inhibitors]. Nemec K; Schubert-Zsilavecz M Pharm Unserer Zeit; 2003; 32(1):11-6. PubMed ID: 12577755 [No Abstract] [Full Text] [Related]
12. Endocrine mechanisms in the pathogenesis of essential hypertension. VI. Blockade of the renin-angiotensin system as a therapeutical basis. Păuşescu E Physiologie; 1982; 19(4):245-64. PubMed ID: 6185963 [No Abstract] [Full Text] [Related]
13. Captopril and teprotide as discriminators of angiotensin-converting enzyme activity in brain tissue. Zubenko GS; Nixon RA Neurosci Lett; 1985 Sep; 60(1):33-7. PubMed ID: 2997673 [TBL] [Abstract][Full Text] [Related]
14. Safety profiles of the angiotensin converting enzyme inhibitors captopril and enalapril. Irvin JD; Viau JM Am J Med; 1986 Oct; 81(4C):46-50. PubMed ID: 3022584 [TBL] [Abstract][Full Text] [Related]
15. Clinical utility of angiotensin converting enzyme inhibitors in hypertension. Gavras I; Gavras H Am J Med; 1986 Oct; 81(4C):28-31. PubMed ID: 3022582 [TBL] [Abstract][Full Text] [Related]
16. Carboxyl-terminal tripeptidyl hydrolysis of substance P by purified rabbit lung angiotensin-converting enzyme and the potentiation of substance P activity in vivo by captopril and MK-422. Cascieri MA; Bull HG; Mumford RA; Patchett AA; Thornberry NA; Liang T Mol Pharmacol; 1984 Mar; 25(2):287-93. PubMed ID: 6199659 [TBL] [Abstract][Full Text] [Related]
17. [Inhibition of the renin-angiotensin system in treating arterial hypertension]. Fagard R; Leuven KU; Staessen J; Amery A Ter Arkh; 1982; 54(11):68-70. PubMed ID: 6186041 [No Abstract] [Full Text] [Related]
18. Effect of chronic captopril treatment on circulating and tissue renin-angiotensin system in SHR rats. Hu WY; Chen DG; Chen SC; Jin XQ; Wang HJ Zhongguo Yao Li Xue Bao; 1996 Nov; 17(6):507-12. PubMed ID: 9863143 [TBL] [Abstract][Full Text] [Related]
19. Captopril reverses the reduced vasodilator response to bradykinin in hypertensive pregnant rats. Resende AC; Pimentel AM; de Moura RS Clin Exp Pharmacol Physiol; 2004 Nov; 31(11):756-61. PubMed ID: 15566389 [TBL] [Abstract][Full Text] [Related]
20. Eotaxin: a VIC (very important chemokine) of allergic inflammation? Baggiolini M J Clin Invest; 1996 Feb; 97(3):587. PubMed ID: 8609209 [No Abstract] [Full Text] [Related] [Next] [New Search]